Literature DB >> 11821278

Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial.

A Nyboe Andersen1, B Popovic-Todorovic, K T Schmidt, A Loft, A Lindhard, A Højgaard, S Ziebe, F Hald, B Hauge, B Toft.   

Abstract

BACKGROUND: The aim was to study whether prolongation of luteal support during early pregnancy influences the delivery rate after IVF.
METHODS: Dual centre study including 303 women who achieved pregnancy after IVF or ICSI was used. All were treated with the long protocol using GnRH agonists and given luteal support with 200 mg vaginal progesterone three times daily during 14 days from the day of transfer until the day of a positive HCG test. The study group (n = 150) withdrew vaginal progesterone from the day of positive HCG. The control group (n = 153) continued administration of vaginal progesterone during the next 3 weeks of pregnancy.
RESULTS: The number of miscarriages prior to and after week 7 of gestation was seven (4.6%) and 15 (10.0%) in the study group and five (3.3%) and 13 (8.5%) in the control group respectively. The number of deliveries was 118 (78.7 %) in the study group and 126 (82.4 %) in the control group. The differences were not significant.
CONCLUSIONS: Prolongation of progesterone supplementation in early pregnancy has no influence on the miscarriage rate, and thus no effect on the delivery rate. Progesterone supplementation can safely be withdrawn at the time of a positive HCG test.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821278     DOI: 10.1093/humrep/17.2.357

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  20 in total

Review 1.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2015-07-07

2.  Comparison of endometrial preparation protocols (natural cycle versus hormone replacement cycle) for frozen embryo transfer (COMPETE): a study protocol for a randomised controlled trial.

Authors:  Xitong Liu; Wen Wen; Tao Wang; Ting Sun; Ting Wang; Na Zhang; Dan Pan; He Cai; Jinlin Xie; Xiaojuan Liu; Zan Shi; Rui Wang; Xiaofang Li; Na Lu; Rong Pan; Li Tian; Bin Meng; Haiyan Bai; Hanying Zhou; Pengfei Qu; Doudou Zhao; Ben W Mol; Wentao Li; Juanzi Shi
Journal:  BMJ Open       Date:  2022-10-14       Impact factor: 3.006

Review 3.  The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis.

Authors:  Xi-Ru Liu; Hua-Qiao Mu; Qi Shi; Xiao-Qiu Xiao; Hong-Bo Qi
Journal:  Reprod Biol Endocrinol       Date:  2012-12-13       Impact factor: 5.211

4.  Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.

Authors:  David M Haas; Taylor J Hathaway; Patrick S Ramsey
Journal:  Cochrane Database Syst Rev       Date:  2019-11-20

5.  Progestogens for preventing miscarriage: a network meta-analysis.

Authors:  Adam J Devall; Argyro Papadopoulou; Marcelina Podesek; David M Haas; Malcolm J Price; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

6.  Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles.

Authors:  Kenan Sofuoglu; Ismet Gun; Sadik Sahin; Okan Ozden; Oktay Tosun; Mustafa Eroglu
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

7.  Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.

Authors:  Jodie M Dodd; Caroline A Crowther; Andrew J McPhee; Vicki Flenady; Jeffrey S Robinson
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-24       Impact factor: 3.007

8.  Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.

Authors:  David M Haas; Taylor J Hathaway; Patrick S Ramsey
Journal:  Cochrane Database Syst Rev       Date:  2018-10-08

9.  Progestogen for treating threatened miscarriage.

Authors:  Hayfaa A Wahabi; Amel A Fayed; Samia A Esmaeil; Khawater Hassan Bahkali
Journal:  Cochrane Database Syst Rev       Date:  2018-08-06

10.  Oocyte retrieval at 140-mmHg negative aspiration pressure: A promising alternative to flushing and aspiration in assisted reproduction in women with low ovarian reserve.

Authors:  Aswathy Kumaran; Pratap Kumar Narayan; Praveena Joglekar Pai; Amar Ramachandran; Basil Mathews; Satish Kumar Adiga
Journal:  J Hum Reprod Sci       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.